Vildagliptin Pharmaceutical Compositions

Patent No. EP3512505 (titled "Vildagliptin Pharmaceutical Compositions") was filed by Galenicum Health SL on Sep 18, 2017. The application was issued on Mar 15, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELKINGTON AND FIFEDec 15, 2023ELKINGTON AND FIFE
KNPP PARTGMBBDec 13, 2023DR VOLGER
KNPP PARTGMBBDec 13, 2023VOLGER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3512505

GALENICUM HEALTH SL
Application Number
EP17768140A
Filing Date
Sep 18, 2017
Status
Granted And Under Opposition
Feb 10, 2023
Publication Date
Mar 15, 2023